GlaxoSmithKline to discontinue Zinetac tablets in India

The company has made a decision to discontinue the manufacture and supply of Zinetac tablets (150 mg and 300 mg products) manufactured in India and will in due course request cancellation of the marketing authorisation associated with the drug, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

The headquarter offices of Glaxosmithkline Plc stand in the Brentford district of London, UK, on Wednesday, Dec. 19, 2018. Photographer: Luke MacGregor/Bloomberg

GlaxoSmithKline Pharmaceuticals on Thursday said it has decided to discontinue production and sale of Zinetac tablets, used to treat and prevent heartburn, in the country.

The company has made a decision to discontinue the manufacture and supply of Zinetac tablets (150 mg and 300 mg products) manufactured in India and will in due course request cancellation of the marketing authorisation associated with the drug, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

In the coming months, the drug firm will work closely with the regulatory authorities, it added.

Story continues below this ad

The drug firm was contacted by regulatory authorities regarding the detection of cancer causing N-Nitrosodimethylamine (NDMA) in Zinetac (ranitidine) products.

Based on the information received and correspondence with regulatory authorities, the company made the decision in September 2019 to initiate a voluntary recall of all ranitidine products in all markets of as a precautionary action.

Tags:
GlaxoSmithKline

exporters not lose market share, labour-intensive exporters, india us trade deal, Trump Tariffs, trump tariff impositions, India-US ties, trade war, us trade war, donald trump, reciprocal tariffs, Trump India trade deal, India US tariff cuts, Trump India tariffs announcement, India US trade agreement, Modi Trump trade talks, India US economic relations, India lowers tariffs for US, US India trade negotiations, Trump Modi tariff deal, India US import export policy, Trump on India tariffs, US India business ties, trade war India US, India trade policy changes, India US tariff reduction, Indian express news, current affairs

On Govt table: How to help exporters not lose market share due to 50% US tariff

Business3 hr ago

The Indian government is implementing strategies to protect its market share from the impact of high US tariffs. This includes providing support to exporters through subsidies, loans, and credit guarantees, as well as helping them access domestic buyers. However, India's export growth to US is lower compared to its competitors, and the situation may worsen with additional tariffs on Russian oil.

View all shorts

Live Blog